Skip to main navigation
Pharvaris N.V. Logo
  • Careers
  • Investors & Media
  • Contact
  • SCIENCE
  • PIPELINE
  • DISEASE FOCUS
  • HAE COMMUNITY
  • CLINICAL TRIALS
  • ABOUT US

Event Details

Investor Menu

IR Nav

  • Overview
  • News & Events
    News Releases Events Publications
  • Financials
    SEC Filings Quarterly Results
  • Stock
    Stock Performance Analyst Coverage
  • Corporate Governance
    Governance Documents Leadership Board of Directors Committee Composition
  • Resources
    Investor FAQs Contact Us Email Alerts

APAAACI 2023 International Conference

Oct 23 - Oct 26, 2023

  • Title: Bradykinin B2 receptor antagonist deucrictibant immediate-release capsule for treatment of HAE attacks: Phase 2 results
    Presenter: Marcus Maurer, M.D.
    Date/Time: Monday, October 23, 11:20-11:30 a.m. SGT (Sunday, October 22, 11:20-11:30 p.m. EDT)

Supporting Materials

Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule for Treatment of HAE Attacks: Phase 2 Results 1.3 MB
Pharvaris N.V. Logo

CONTACT US

FOLLOW US

linkedin logo Facebook icon

©2026 Pharvaris N.V. © All Rights Reserved

  • Privacy Policy
  • Clinical Trial Privacy Notice
  • Global Privacy Laws
  • Terms of Use